Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
4
×
indiana blog main
indiana top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston top stories
alnylam pharmaceuticals
clinical trials
deals
fda
imara
sanofi
abbvie
acc
acquisition
activist investor
aducanumab
akouos
allergan
What
help
4
×
bio
drug
roundup
news
acquisitions
adu
alzheimer's
announced
approved
aren’t
bad
beats
bids
biogen
brain
cancer
case
ceo
collabs
complicated
covid
daniel
deal
depression
developers
dire
disease
doses
drugs
failed
fda
fight
fortune
gene
gilead
gilead’s
goes
good
group
Language
unset
Current search:
national
×
help
×
" detroit top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More